BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus

  June 1, 2026

   · 

  5 min read
• Press Releases

  Xenetic Biosciences Showcases Compelling ASCO 2026 Data Demonstrating DNase I Significantly Enhances CAR-T Cell Persistence, Tumor Control, and Survival

  June 1, 2026

   · 

  7 min read
• Press Releases

  Revelation Biosciences Expands Acute Kidney Injury Advisory Board

  June 1, 2026

   · 

  6 min read
• Press Releases

  Promising Phase 1 Data for Servier’s Emiltatug Ledadotin (Emi-Le) in Adenoid Cystic Carcinoma (ACC) Presented at ASCO 2026

  June 1, 2026

   · 

  5 min read
• Press Releases

  Veritas Aortic Solutions, an inQB8 Spinout, Raises $12M to Advance Non-Surgical Treatment of Aortic Root and Ascending Aortic Diseases

  June 1, 2026

   · 

  5 min read
• Press Releases

  Paradigm Health Implements New Clinical Trial Solution to Support Observational Study Presented at ASCO

  June 1, 2026

   · 

  5 min read
• Press Releases

  Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance

  June 1, 2026

   · 

  5 min read
• 

  Job Trends

  17 companies expected to create 400+ Massachusetts jobs add under 50

  Seventeen life sciences businesses awarded Massachusetts tax incentives to add and retain 426 combined jobs hit 10% of that target as of Dec. 31. Three companies, including Novartis, had reported layoffs either last year or this year.

  June 1, 2026

   · 

  4 min read

   · 

  Angela Gabriel
• 

  Mergers & acquisitions

  Servier frees Edgewise for cardio mission with $2.65B muscular dystrophy deal

  Edgewise Therapeutics will now focus on a handful of cardiovascular programs including EDG-7500 for hypertrophic cardiomyopathy thanks to the non-dilutive capital from France’s Servier.

  June 1, 2026

   · 

  2 min read

   · 

  Annalee Armstrong
• 

  Manufacturing

  CordenPharma inks AmbioPharm buyout to continue peptide production expansion

  Swiss service provider CordenPharma is acquiring AmbioPharm, gaining facilities such as a plant in South Carolina to provide a fully U.S.-based supply.

  June 1, 2026

   · 

  2 min read

   · 

  Nick Paul Taylor